Back
11
Day Range
$26.65
$29.15
52-Week Range
$18.61
$33.86
Volume
8,077
50D / 200D Avg
$29.58
/
$26.16
Prev Close
$27.00
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.0 | 10.4 |
| P/B | 0.0 | 1.2 |
| ROE % | 23.9 | 12.3 |
| Net Margin % | 8.0 | 5.2 |
| Rev Growth 5Y % | 6.4 | 5.5 |
| D/E | 1.0 | 0.6 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$2.53
$2.29 – $2.67
|
4200 B | 2 |
| FY2028 |
$2.52
$2.28 – $2.66
|
4100 B | 3 |
| FY2027 |
$2.23
$1.77 – $2.56
|
3800 B | 4 |
Key Takeaways
Revenue grew 6.42% annually over 5 years — modest growth
ROE of 23.91% indicates high profitability
Generating 174.30B in free cash flow
P/E of 0.02 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 13.11%
Capital efficient — spends only 8.31% of revenue on capex
Growth
Revenue Growth (5Y)
6.42%
Revenue (1Y)-6.69%
Earnings (1Y)3.88%
FCF Growth (3Y)0.05%
Quality
Return on Equity
23.91%
ROIC13.46%
Net Margin8.03%
Op. Margin13.09%
Safety
Debt / Equity
1.00
Current Ratio1.41
Interest Coverage6.42
Valuation
P/E Ratio
0.02
P/B Ratio0.00
EV/EBITDA2.08
Dividend Yield0.05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6.69% | Revenue Growth (3Y) | 7.69% |
| Earnings Growth (1Y) | 3.88% | Earnings Growth (3Y) | 19.29% |
| Revenue Growth (5Y) | 6.42% | Earnings Growth (5Y) | 10.23% |
| Profitability | |||
| Revenue (TTM) | 3.18T | Net Income (TTM) | 255.50B |
| ROE | 23.91% | ROA | 7.34% |
| Gross Margin | 39.08% | Operating Margin | 13.09% |
| Net Margin | 8.03% | Free Cash Flow (TTM) | 174.30B |
| ROIC | 13.46% | FCF Growth (3Y) | 0.05% |
| Safety | |||
| Debt / Equity | 1.00 | Current Ratio | 1.41 |
| Interest Coverage | 6.42 | Dividend Yield | 0.05% |
| Valuation | |||
| P/E Ratio | 0.02 | P/B Ratio | 0.00 |
| P/S Ratio | 0.00 | PEG Ratio | 3.86 |
| EV/EBITDA | 2.08 | Dividend Yield | 0.05% |
| Market Cap | 4.21B | Enterprise Value | 868.07B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.18T | 3.41T | 2.74T | 2.61T | 2.48T |
| Net Income | 255.50B | 245.96B | 179.56B | 123.21B | 173.07B |
| EPS (Diluted) | 1699.82 | 1636.72 | 1196.74 | 814.77 | 1149.07 |
| Gross Profit | 1.24T | 1.35T | 1.06T | 1.01T | 941.28B |
| Operating Income | 416.46B | 419.74B | 367.27B | 340.35B | 311.58B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.48T | 3.29T | 2.92T | 3.01T | 2.95T |
| Total Liabilities | 2.28T | 2.28T | 2.00T | 2.13T | 1.84T |
| Shareholders' Equity | 1.16T | 976.41B | 886.29B | 855.26B | 1.08T |
| Total Debt | 1.16T | 1.12T | 1.03T | 1.14T | 1.07T |
| Cash & Equivalents | 296.54B | 248.90B | 303.68B | 291.68B | 304.31B |
| Current Assets | 1.04T | 1.01T | 981.77B | 1.16T | 990.99B |
| Current Liabilities | 732.51B | 906.14B | 692.87B | 949.25B | 529.57B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#517 of 658
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026